• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Global Nanotechnology Drug Delivery Market 2012-2016 Product Image

Global Nanotechnology Drug Delivery Market 2012-2016

  • Published: March 2013
  • Region: Global
  • 35 pages
  • TechNavio

FEATURED COMPANIES

  • AlphaRx Inc.
  • Celgene Corp.
  • CytImmune Sciences Inc.
  • GlaxoSmithKline plc
  • Merck & Co. Inc.
  • NanoSight Ltd.
  • MORE

TechNavio's analysts forecast the Global Nanotechnology Drug Delivery market to grow at a CAGR of 73.97 percent over the period 2012-2016. One of the key factors contributing to this market growth is the low R&D cost. The Global Nanotechnology Drug Delivery market has also been witnessing an increase in customer support services. However, the increasing safety concerns could pose a challenge to the growth of this market.

TechNavio's report, Global Nanotechnology Drug Delivery Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it covers the Global Nanotechnology Drug Delivery market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this space are IOTA NanoSolutions Ltd., Lena Nanoceutics Ltd., GlaxoSmithKline plc, Celgene Corp., and SkyePharma plc.

The other vendors mentioned in the report are Merck & Co. Inc., Pfizer Inc., AlphaRx Inc., Amgen Inc., Angiotech Pharmaceuticals Inc., Biophan Technologies Inc., Calando Pharmaceuticals READ MORE >

01. Executive Summary
02. List of Abbreviations
03. Introduction
04. Market Coverage
Market Overview
Key Offerings
05. Market Landscape
05.1 Market Size and Forecast
05.2 Market Segmentation of the Global Nanotechnology Drug Delivery Market
Market Segmentation by Technology
05.3 Five Forces Analysis
06. Geographical Segmentation
07. Vendor Landscape
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Key Vendor Analysis
14.1 IOTA NanoSolutions Ltd.
Business Overview
SWOT Analysis
14.2 Celgene Corp.
Business Overview
Key Information
SWOT Analysis
14.3 GlaxoSmithKline plc
Business Overview
SWOT Analysis
14.4 Lena Nanoceutics Ltd.
Business Overview
Key Information
SWOT Analysis
14.5 SkyePharma plc
Business Overview
SWOT Analysis
15. Other Reports in this Series

List of Exhibits
Exhibit 1: Global Nanotechnology Drug Delivery Market 2012-2016(US$ billion)
Exhibit 2: Global Nanotechnology Drug Delivery Market Segmentation by Technology
Exhibit 3: Global Nanotechnology Drug Delivery Market Segmentation 2012 (percentage)
Exhibit 4: Global Nanocarrier Market Share by Technology 2012 (percentage)
Exhibit 5: Global Nanotechnology Drug Delivery Market by Geographical Segmentation 2012

TechNavio Announces the Publication of its Research Report - Global Nanotechnology Drug Delivery Market 2012-2016

TechNavio today launched its report Global Nanotechnology Drug Delivery Market 2012-2016 based on an in-depth analysis covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers' understanding of the present and future landscape of the market.

Commenting on the report, an analyst from TechNavio's Healthcare team said: ''Pharmaceutical and biotechnology companies are focusing on capitalizing on the potential of nanotechnology-enabled drug delivery. Nanotechnology-enabled drug delivery systems are helping pharmaceutical and biotechnology companies to counter the threat of generics. Reformulation helps in extending the product life cycle, and novel reformulations help an existing drug candidate to qualify as a new chemical entity. This increases profitability and discourages competition during the drug's most profitable years.''

According to the report, increasing government funding is one of the major drivers in the Global Nanotechnology Drug Delivery market. Government programs in various countries such as the US, the UK, Germany, and China exist for funding various R&D initiatives in nanotechnology, which is boosting the growth of the market.

Further, the report states that various manufacturing issues constitute one of the major challenges in the Global Nanotechnology Drug Delivery Market.

The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this market space are Celgene Corp., GlaxoSmithKline plc, IOTA NanoSolutions Ltd., Lena Nanoceutics Ltd., and SkyePharma plc. The other vendors mentioned in the report are Merck & Co. Inc., Pfizer Inc., AlphaRx Inc., Amgen Inc., Angiotech Pharmaceuticals Inc., Biophan Technologies Inc., Calando Pharmaceuticals Inc., Cephalon Inc., Cerulean Pharma Inc., Copernicus Therapeutics Inc., CritiTech Inc., CytImmune Sciences Inc., Elan Corp. plc, Debiotech SA, F. Hoffmann-La Roche Ltd., Nano Interface Technology Inc., Spherics Inc., Spectrum Pharmaceuticals Inc., SoluBest Ltd., Sigma-Tau Pharmaceuticals Inc., PharmaNova Inc., Particle Sciences Inc., Novavax Inc., Nanotherapeutics Inc., NanoSight Ltd., NanoCarrier Co. Ltd., NanoBioMagnetics Inc., Nano Interface Technology Inc., Merck Sharp and Dohme Corp., Kuecept Ltd., and Izon Science Ltd.

- Celgene Corp.
- GlaxoSmithKline plc
- IOTA NanoSolutions Ltd.
- Lena Nanoceutics Ltd.
- SkyePharma plc.
- Merck & Co. Inc.
- Pfizer Inc.
- AlphaRx Inc.
- Amgen Inc.
- Angiotech Pharmaceuticals Inc.
- Biophan Technologies Inc.
- Calando Pharmaceuticals Inc.
- Cephalon Inc.
- Cerulean Pharma Inc.
- Copernicus Therapeutics Inc.
- CritiTech Inc.
- CytImmune Sciences Inc.
- Elan Corp. plc
- Debiotech SA
- F. Hoffmann-La Roche Ltd.
- Nano Interface Technology Inc.
- Spherics Inc.
- Spectrum Pharmaceuticals Inc.
- SoluBest Ltd.
- Sigma-Tau Pharmaceuticals Inc.
- PharmaNova Inc.
- Particle Sciences Inc.
- Novavax Inc.
- Nanotherapeutics Inc.
- NanoSight Ltd.
- NanoCarrier Co. Ltd.
- NanoBioMagnetics Inc.
- Nano Interface Technology Inc.
- Merck Sharp & Dohme Corp.
- Kuecept Ltd.
- and Izon Science Ltd.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos